Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


BioMarin Pharmaceutical Inc. 

105 Digital Drive

Novato  California  94949  U.S.A.
Phone: 415-506-6700 Fax: 415-382-7427



 Company News
Analyst: First Quarter of 2015 Crucial to ProSensa Holding N.V. (RNA), BioMarin Pharmaceutical Inc. (BMRN) Deal 11/25/2014 4:37:51 PM
BioMarin Pharmaceutical Inc. (BMRN), ProSensa Holding N.V. (RNA) Marriage Makes Sense for Investors If Regulatory Hurdles Can Be Overcome 11/24/2014 1:41:33 PM
BioMarin Pharmaceutical Inc. (BMRN) Acquires ProSensa Holding N.V. (RNA) For Up To $840M; Gaining Experimental Drisapersen 11/24/2014 5:41:26 AM
BioMarin Pharmaceutical Inc. (BMRN) To Attend Upcoming Investor Conferences 11/19/2014 12:51:37 PM
Biotech Investors Bullish On Large Cap; Citi Adds Vertex Pharmaceuticals (MA) (VRTX), BioMarin Pharmaceutical Inc. (BMRN) and Tesaro, Inc. (TSRO) To Most Preferred 11/14/2014 3:27:58 PM
Jean-Jacques Bienaime, CEO Of BioMarin Pharmaceutical Inc. (BMRN), To Present At The Credit Suisse 2014 Healthcare Conference 11/4/2014 10:10:45 AM
BioMarin Pharmaceutical Inc. (BMRN),Incyte Corporation (INCY) Part Of Rally As Biotech Sector Booms, Says Cowen 11/3/2014 2:44:39 PM
BioMarin Pharmaceutical Inc. (BMRN) Announces Third Quarter 2014 Financial Results 10/24/2014 10:16:03 AM
BioMarin Pharmaceutical Inc. (BMRN) To Host Third Quarter 2014 Financial Results Conference Call And Webcast On Thursday, October 23 At 4:30pm ET 10/8/2014 7:18:12 AM
BioMarin Pharmaceutical Inc. (BMRN) Release: FDA Receives Paragraph IV Notice Letter for KUVAN® (sapropterin dihydrochloride) Tablets 9/25/2014 7:54:04 AM